Overview
- Description
The company is pioneering next-generation programmable gene-writing tools—most notably its proprietary FiCAT platform—to revolutionise gene and cell therapies for genetic disorders and treatment-resistant cancers with enhanced precision, efficiency, and safety.
- Website
- Country
- Spain
- Sector
- Health Biotechnology
Engage with INTEGRA THERAPEUTICS*
*By clicking here you will be leaving the official EIC website and you will be directed to the Dealroom.co domain, an official EISMEA contractor for the EIC investor matchmaking platform.